Figure 1
Power hearing aids in their makers' words
| Oticon | Xceed BTE Super Power and BTE Ultra Power | Behind-the-ear; Oticon calls the family super- and ultra-power hearing aids | Super Power and Ultra Power, as the model names | November 3, 2026 |
|---|---|---|---|---|
| Phonak | Naída Lumity (sheet names L-PR, L-M, L-SP and L-UP) | Behind-the-ear portfolio for mild to profound losses | Widest fitting range on the product sheet: severe to profound | November 3, 2026 |
| ReSound | Enzo IA | Rechargeable Super Power hearing aids | Severe to profound | November 3, 2026 |
| Signia | Motion Charge&Go SP IX | Rechargeable behind-the-ear with super-power amplification | Profound | November 2, 2026 |
| Widex | Allure BTE R D | Behind-the-ear (BTE) | Mild to profound | November 3, 2026 |
Figure 2
FDA records for each power model
| Oticon Xceed (BTE SP and BTE UP records) | Oticon Xceed | Oticon A/S | OSM | 44 | 44 | 0 |
|---|---|---|---|---|---|---|
| Phonak Naída L (SP and UP brand names) | Phonak Naida L | Sonova AG | OSM | 64 | 0 | 0 |
| ReSound Enzo IA | Enzo IA | GN Hearing A/S | OSM | No GUDID field names this model | No GUDID field names this model | No GUDID field names this model |
| Signia Motion C&G SP IX | Motion Charge&Go IX | Sivantos GmbH | OSM | 69 | 69 | 0 |
| Starkey G Series AI UP BTE 13 | Starkey G Series AI | Starkey Laboratories, Inc. | OSM | 9 | 9 | 0 |
| Widex Allure | Widex Allure | WS Audiology A/S | OSM | No GUDID field names this model | No GUDID field names this model | No GUDID field names this model |
- FDA, registration and listing database (openFDA),api.fda.gov/device/registrationlisting.json
- FDA, registration and listing database (openFDA),api.fda.gov/device/registrationlisting.json
- FDA, registration and listing database (openFDA),api.fda.gov/device/registrationlisting.json
- FDA, registration and listing database (openFDA),api.fda.gov/device/registrationlisting.json
- FDA, registration and listing database (openFDA),api.fda.gov/device/registrationlisting.json
- FDA, registration and listing database (openFDA),api.fda.gov/device/registrationlisting.json
- FDA, GUDID (openFDA),api.fda.gov/device/udi.json
- FDA, GUDID (openFDA),api.fda.gov/device/udi.json
- FDA, GUDID (openFDA),api.fda.gov/device/udi.json
- FDA, GUDID (openFDA),api.fda.gov/device/udi.json
Figure 3
Power hearing aid lines in a hospital price file
| HC NAIDA L30-UP-BIN-PHONAK | Phonak Naída L | V5261 | 756.94 | April 1, 2026 |
|---|---|---|---|---|
| HC NAIDA L90-UP-BIN-PHONAK | Phonak Naída L | V5261 | 2252.62 | April 1, 2026 |
| HC XCEED 3 BTE SP/UP-BIN-OTICON | Oticon Xceed | V5261 | 805.50 | April 1, 2026 |
| HC XCEED 1 BTE SP/UP-BIN-OTICON | Oticon Xceed | V5261 | 2065.50 | April 1, 2026 |
- eCFR, 45 CFR part 180, hospital price transparency
- University of California Davis Medical Center, file dated April 1, 2026: price transparency page, price file
How to read these numbers (5)
- Rows run alphabetically by maker. They are not a ranking and say nothing about how a model performs or which one suits a given ear.
- Makers' wording is quoted or closely paraphrased from their US pages and product sheet, on the reading date shown; a short quote per cell, models that meet the page's criterion only. A maker's wording is removed on its written request.
- An FDA registration listing is a firm's filing and does not denote FDA approval, clearance or authorization. Product code OSM is FDA's code for a prescription air-conduction hearing aid with wireless technology.
- GUDID flags are the labeler's own entries; Sonova leaves both flags unset on its Naída L SP and UP records.
- Discounted cash price posted by the hospital under 45 CFR 180 (the charge that applies to an individual who pays cash), hospital charge only, as of the date in the hospital's file. Not a quote and not what you will pay with insurance. Lines removed on written request.
How the six models on this page were picked
The first results for this search pick winners. A hearing clinic's blog ranks four brands, a hearing aid seller scores models on five factors of its own, and a consumer guide reviews over-the-counter models. This page names no winner. A model enters the tables for one checkable reason: its maker's own US page or product sheet writes a hearing loss range that reaches severe or profound, or the maker calls it a super-power or ultra-power aid.
Five makers pass that test with a behind-the-ear power model: Oticon, Phonak, ReSound, Signia and Widex. Starkey's G Series AI UP BTE 13 appears in the FDA table only, under the model name its GUDID record carries: Starkey's site terms forbid automated reading, so no Starkey wording is quoted here. Rows run in alphabetical order. No model was tried, scored or compared on sound, and the choice and fitting belong to a hearing care professional who has your test results. Over-the-counter aids are left out: the FDA rule at 21 CFR 800.30 covers adults 18 or older with perceived mild to moderate impairment, and our OTC hearing aids page covers that route.
What each maker writes about its power hearing aid
ReSound is the most direct. Its Enzo IA page describes "the smallest rechargeable Super Power hearing aids for severe to profound hearing loss". Phonak's product information sheet for Naída Lumity covers a behind-the-ear portfolio for mild to profound losses, names the L-PR, L-M, L-SP and L-UP models, and the widest fitting range it prints reads severe to profound. Signia's catalog files the Motion Charge&Go SP IX under profound hearing loss and calls it a rechargeable behind-the-ear aid with super-power amplification.
Oticon uses the name rather than a range: it lists Xceed BTE Super Power and Xceed BTE Ultra Power and presents the family as super- and ultra-power hearing aids. Widex writes the widest span: its Allure BTE R D page says the behind-the-ear aid serves people with mild to profound hearing loss.
A range on a maker page is the span the device is built for. It is not a promise about any one ear, and Phonak's sheet draws its ranges as audiogram charts that we do not redraw as decibel limits.
Are power hearing aids prescription devices? What FDA records show
Each of the six families appears by name in FDA's registration and listing database, and every maker's own listing carries product code OSM. FDA's classification record names that code "Hearing Aid, Air-Conduction With Wireless Technology, Prescription", places it at 21 CFR 874.3305 in class 2, and marks it exempt from premarket notification. The listings are filed by GN Hearing A/S for Enzo IA, Oticon A/S for Oticon Xceed, Sivantos GmbH for Motion Charge&Go IX, Sonova AG for Phonak Naida L, Starkey Laboratories, Inc. for Starkey G Series AI and WS Audiology A/S for Widex Allure. A listing is a firm's filing, not an FDA approval or clearance.
The FDA's device identifier database, GUDID, goes down to the model. Starkey holds 9 records for G Series AI UP BTE 13 and flags all 9 as prescription; Signia holds 69 for Motion C&G SP IX, all 69 flagged prescription; Oticon holds 44 for Xceed BTE SP and BTE UP, all 44 flagged prescription. None of these is flagged over the counter. Sonova's 64 records for the Naída L SP and UP brand names leave both flags unset, so GUDID neither confirms nor denies the route for them. For Enzo IA and Allure, no GUDID field names the model the way the maker page does, so the table shows the listing only.
What a hospital charges for a power hearing aid: UC Davis price file
None of the maker pages read for this page prints a price. One public file does name power models: the price file of University of California Davis Medical Center, dated April 1, 2026, posted under the federal hospital price transparency rule. Under code V5261, a binaural behind-the-ear aid, it posts a discounted cash price of $756.94 for its line HC NAIDA L30-UP-BIN-PHONAK and $2,252.62 for HC NAIDA L90-UP-BIN-PHONAK. For Oticon it posts $805.50 for HC XCEED 3 BTE SP/UP-BIN-OTICON and $2,065.50 for HC XCEED 1 BTE SP/UP-BIN-OTICON.
These are the hospital's own charges for its own lines, read as posted. Each line is billed as a pair (BIN), and the file does not say what the line includes, such as fitting visits or follow-up. They are not store prices, not a quote and not what you will pay with insurance. The hospital's price transparency page and the file itself are linked under the table, and any line comes off this page on written request from the hospital. Other hospitals' hearing aid charges, by code, are on our page on what hearing aids cost.
Who pays for a prescription power hearing aid
What you pay depends on the payer more than on the model. Medicaid rules for adult hearing aids differ by state and are set out on Medicaid and hearing aids; veterans' devices follow VA rules on VA hearing aids. If a hearing care professional raises an implant instead of a power aid, the cost comparison is on cochlear implant or hearing aid. Before buying, ask the clinic for a written quote that lists the device, the fitting visits and the follow-up included.
Frequently asked questions
What are the best affordable hearing aids for severe hearing loss?
No maker page we read prices its power model, so affordability can't be ranked from them. One public reference is a hospital price file: UC Davis Medical Center posts a discounted cash price of $756.94 for its binaural Naída L30-UP line and $805.50 for Xceed 3 BTE SP/UP, against $2,252.62 for Naída L90-UP, in a file dated April 1, 2026. Those are hospital charges, not store prices. Over-the-counter aids are outside the FDA's OTC category, which covers perceived mild to moderate loss. Links to the hospital file are under the table above.
What is the best hearing aid for someone with profound hearing loss?
This page doesn't rank models; a licensed professional chooses and fits one from your hearing test. Among the makers' own pages, Signia files Motion Charge&Go SP IX under profound hearing loss, ReSound writes severe to profound for Enzo IA, Phonak's Naída Lumity sheet reaches severe to profound, and Oticon names its Xceed models Super Power and Ultra Power.
Sources
Models and ranges come from the US pages and product sheet of six makers, read in November 2026, quoted or paraphrased with attribution; the criterion was fixed before reading and no model was tried, scored or ranked. FDA listings, the OSM classification and GUDID records were read through openFDA on November 3, 2026. Hospital lines are copied as posted from the UC Davis Medical Center price file under 45 CFR 180.
- https://www.phonak.com/content/dam/celum/phonak/master-assets/documents/hearing-instruments/lumity/naida/product-information/ph-product-information-naida-l-210x280-027-0699-02.pdf
- https://www.oticon.com/products/hearing-aids/family/xceed
- https://www.signia.net/en-us/hearing-aids/types/
- https://www.ecfr.gov/api/renderer/v1/content/enhanced/current/title-21?part=800§ion=800.30
- https://www.resound.com/en-us/hearing-aids/resound-hearing-aids/resound-enzo-ia
- https://www.widex.com/en-us/hearing-aids/allure/bte-r-d/
- https://api.fda.gov/device/registrationlisting.json?search=proprietary_name%3A%22Phonak+Naida+L%22&limit=100
- https://api.fda.gov/device/registrationlisting.json?search=proprietary_name%3A%22Oticon+Xceed%22&limit=100
- https://api.fda.gov/device/registrationlisting.json?search=proprietary_name%3A%22Enzo+IA%22&limit=100
- https://api.fda.gov/device/registrationlisting.json?search=proprietary_name%3A%22Motion+Charge%26Go+IX%22&limit=100
- https://api.fda.gov/device/registrationlisting.json?search=proprietary_name%3A%22Starkey+G+Series+AI%22&limit=100
- https://api.fda.gov/device/registrationlisting.json?search=proprietary_name%3A%22Widex+Allure%22&limit=100
- https://api.fda.gov/device/classification.json?search=product_code%3AOSM&limit=5
- https://api.fda.gov/device/udi.json?search=company_name.exact%3A%22Sonova+AG%22&count=brand_name.exact&limit=1000
- https://api.fda.gov/device/udi.json?search=company_name.exact%3A%22Oticon+A%2FS%22+AND+device_description%3Axceed&limit=100
- https://api.fda.gov/device/udi.json?search=company_name.exact%3A%22Ws+Audiology+Usa%2C+Inc.%22+AND+version_or_model_number%3A%22Motion+C%26G+SP%22&limit=100
- https://api.fda.gov/device/udi.json?search=company_name.exact%3A%22Starkey+Laboratories%2C+Inc.%22+AND+version_or_model_number%3A%22G+Series+AI%22+AND+version_or_model_number%3AUP&limit=100
- https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-E/part-180
Cost and coverage research, not medical advice. A maker's fitting range is not a recommendation: a hearing care professional chooses and fits a hearing aid from your hearing test.